ENO2 and neuroblastoma: A noteworthy study by Barve et al. has centered its attention on the identification of Neuron-Specific Enolase (NSE) as a pivotal biomarker derived from neuroendocrine cells.89 SE, an acid-based protease serum component, is extracted explicitly from neuroblastoma sources.